Epigenetic compound screening reveals new therapeutic targets for chordoma

Ähnliche Einträge

• Inhibition of histone H3K27 demethylases inactivates brachyury (TBXT) and promotes chordoma cell death
  von: Cottone, L, et al.
  Veröffentlicht: (2020)
• The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
  von: Shalaby, A, et al.
  Veröffentlicht: (2011)
• Epigenetics: Novel Therapeutics Targeting Epigenetics.
  von: Conway, S, et al.
  Veröffentlicht: (2014)
• Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
  von: Tirabosco, R, et al.
  Veröffentlicht: (2008)
• Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
  von: Sheppard, Hadley E, et al.
  Veröffentlicht: (2021)